CBS New York - July 12, 2019
Richard Lipton, M.D., discusses his New England Journal of Medicine study on rimegepant, a drug belonging to a new generation of acute migraine headache treatments that was found to eliminate pain and reduce bothersome symptoms. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the Montefiore Headache Center.
More Coverage on this Story
US News & World Report (via HealthDay)
Dr. Lipton's ProfileMore coverage on Dr. Lipton
UPI - July 3, 2019
Paul Frenette, M.D., explains his research on a beta blocker that significantly reduced men’s risk of intermediate- and low-grad prostate cancer. Dr. Frenette is professor of medicine and of cell biology, and chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.
Dr. Frenette's ProfileMore coverage on Dr. Frenette
The New York Times - July 3, 2019
Lauren Sydney Flicker, J.D., addresses the ethical considerations of a court ruling allowing the parents of a deceased man to control the disposition of sperm harvested from his body. Ms. Flicker is associate professor of epidemiology and population health at Einstein and associate director of the Montefiore Einstein Center for Bioethics.
Ms. Flicker's ProfileMore coverage on Ms. Flicker
WSJ - July 3, 2019
Parsa Mirhaji, M.D., Ph.D., describes the successful use of artificial intelligence at Montefiore and Einstein to predict acute respiratory failure. Dr. Mirhaji is research associate professor of systems and computational biology at Einstein and director of the Montefiore Einstein Center for Health Data Innovations.
Dr. Mirhaji's Profile
BBC News - July 3, 2019
Qibin Qi, Ph.D., discusses his European Heart Journal research that found postmenopausal women with normal BMI who are “apple-shaped” face a greater risk of developing cardiovascular disease than those who are “pear-shaped.” Dr. Qi is associate professor of epidemiology & population health at Einstein.
More Coverage on this Story
The New York Times
Dr. Qi's Profile
Associated Press - July 2, 2019
Emad Eskandar, M.D., comments on the risks and regulations that have limited U.S. clinical trials on deep brain stimulation for addiction. Dr. Eskandar is professor and chair of The Leo M. Davidoff Department of Neurological Surgery and the Jeffrey P. Bergstein Chair in Neurological Surgery at Einstein and Montefiore.
Dr. Eskandar's Profile
The Scientist - June 20, 2019
The research of Robert Singer, Ph.D., and colleagues has illuminated our understanding of gene activation, or transcription. Dr. Singer is professor and co-chair of anatomy & structural biology, the Harold and Muriel Block Chair in Anatomy & Structural Biology, and co-director of the Gruss-Lipper Biophotonics Center.
Dr. Singer's ProfileMore coverage on Dr. Singer
WSJ - June 20, 2019
Tia Powell, M.D., explores the new technologies, tools, and services that can help people with dementia remain in their homes longer and avoid going to nursing homes. Dr. Powell is the Shoshana Trachtenberg Frackman Faculty Scholar in Biomedical Ethics and director of the Montefiore Einstein Center for Bioethics.
Dr. Powell's ProfileMore coverage on Dr. Powell
Scientific American - June 20, 2019
Eric Hollander, M.D., comments on the results of two clinical trials, one of which he led, that found hormone-altering drugs seemed to improve social communication in patients with autism. Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Einstein and Montefiore.
Dr. Hollander's ProfileMore coverage on Dr. Hollander
The New York Times - May 8, 2019
Joe Verghese, M.B.B.S., discusses his New England Journal of Medicine study that found dancing was associated with a reduced risk of developing dementia. Dr. Verghese is chief of geriatrics at Einstein and Montefiore and director of the Montefiore Einstein Center for the Aging Brain.
Dr. Verghese's ProfileMore coverage on Dr. Verghese
The Scientist - April 8, 2019
William Jacobs Jr., Ph.D., talks about the development of tuberculosis infections in humans on immune-boosting cancer treatments. Dr. Jacobs is professor of microbiology & immunology and of genetics and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.
Dr. Jacobs' ProfileMore coverage on Dr. Jacobs
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
More coverage on
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder